Nanosensors for therapeutic drug monitoring: implications for transplantation

Nanomedicine (Lond). 2019 Oct;14(20):2735-2747. doi: 10.2217/nnm-2019-0150. Epub 2019 Oct 16.

Abstract

The number of patients requiring organ transplantations is exponentially increasing. New organs are either provided by healthy or deceased donors, or are grown in laboratories by tissue engineers. Post-surgical follow-up is vital for preventing any complications that can cause organ rejection. Physiological monitoring of a patient who receives newly transplanted organs is crucial. Many efforts are being made to enhance follow-up technologies for monitoring organ recipients, and point-of-care devices are beginning to emerge. Here, we describe the role of biosensors and nanosensors in improving organ transplantation efficiency, managing post-surgical follow-up and reducing overall costs. We provide an overview of the state-of-the-art biosensing technologies and offer some perspectives related to their further development.

Keywords: biosensing technology; organ transplantation; point-of-care medicine; therapeutic drug monitoring.

Publication types

  • Review

MeSH terms

  • Biosensing Techniques*
  • Drug Monitoring*
  • Graft Rejection / drug therapy*
  • Graft Rejection / pathology
  • Humans
  • Organ Transplantation / methods*
  • Postoperative Care
  • Tissue Engineering / trends